{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:50:50Z","timestamp":1792443050929,"version":"4.5.0"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Renal Association"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,29]]},"DOI":"10.1093\/ndt\/gfag020","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T12:48:15Z","timestamp":1770209295000},"page":"991-997","source":"Crossref","is-referenced-by-count":1,"title":["Albuminuria or proteinuria in glomerular disease and CKD\u2014which one to use?"],"prefix":"10.1093","volume":"41","author":[{"given":"Vanja","family":"Ivkovi\u0107","sequence":"first","affiliation":[{"name":"Medicine and Caring Sciences, Link\u00f6ping University Department of Health, , Link\u00f6ping ,","place":["Sweden"]},{"name":"Hypertension, Dialysis and Transplantation, University Hospital Center Zagreb Department of Nephrology, , Zagreb,","place":["Croatia"]},{"name":"Faculty of Health Studies, University of Rijeka , Rijeka ,","place":["Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kronbichler","sequence":"additional","affiliation":[{"name":"Medicine and Caring Sciences, Link\u00f6ping University Department of Health, , Link\u00f6ping ,","place":["Sweden"]},{"name":"Nephrology and Hypertension, Medical University Innsbruck Department of Internal Medicine IV, , Innsbruck ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Kay","family":"Cheung","sequence":"additional","affiliation":[{"name":"University of Leicester Mayer IgA Nephropathy Laboratories, Department of Cardiovascular Sciences, , Leicester ,","place":["UK"]},{"name":"John Walls Renal Unit, University Hospitals Leicester NHS Trust , Leicester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Barratt","sequence":"additional","affiliation":[{"name":"University of Leicester Mayer IgA Nephropathy Laboratories, Department of Cardiovascular Sciences, , Leicester ,","place":["UK"]},{"name":"John Walls Renal Unit, University Hospitals Leicester NHS Trust , Leicester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9752-9941","authenticated-orcid":false,"given":"Annette","family":"Bruchfeld","sequence":"additional","affiliation":[{"name":"Medicine and Caring Sciences, Link\u00f6ping University Department of Health, , Link\u00f6ping ,","place":["Sweden"]},{"name":"Karolinska University Hospital and CLINTEC Karolinska Institutet Department of Renal Medicine, , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Floege","sequence":"additional","affiliation":[{"name":"RWTH Aachen University Hospital Department of Nephrology and Department of Cardiology, , Aachen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Vaglio","sequence":"additional","affiliation":[{"name":"Experimental and Clinical Sciences \u201cMario Serio\u201d, University of Florence Department of Biomedical, , Florence ,","place":["Italy"]},{"name":"Nephrology and Dialysis Unit, Meyer Children\u2019s Hospital IRCCS , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"2026052900270684600_bib1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/B978-0-12-815876-0.00015-2","article-title":"Pathophysiology of proteinuria: albuminuria as a target for treatment","volume-title":"Chronic Renal Disease","author":"Heerspink","year":"2020","edition":"2nd edn."},{"key":"2026052900270684600_bib2","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1046\/j.1523-1755.2003.00840.x","article-title":"Pathophysiology of proteinuria","volume":"63","author":"D\u2019Amico","year":"2003","journal-title":"Kidney Int"},{"key":"2026052900270684600_bib3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41581-024-00914-1","article-title":"Protein handling in kidney tubules","volume":"21","author":"Hall","year":"2025","journal-title":"Nat Rev Nephrol"},{"key":"2026052900270684600_bib4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/ndt\/gfad215","article-title":"Tubular toxicity of proteinuria and the progression of chronic kidney disease","volume":"39","author":"Makhammajanov","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2026052900270684600_bib5","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.kint.2023.08.008","article-title":"Measuring albuminuria or proteinuria: does one answer fit all?","volume":"104","author":"Harrison","year":"2023","journal-title":"Kidney Int"},{"key":"2026052900270684600_bib6","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","journal-title":"Kidney Int"},{"key":"2026052900270684600_bib7","doi-asserted-by":"publisher","first-page":"e08253","DOI":"10.1016\/j.heliyon.2021.e08253","article-title":"Diagnostic accuracy of urine dipstick testing for albumin-to-creatinine ratio and albuminuria: a systematic review and meta-analysis","volume":"7","author":"Mejia","year":"2021","journal-title":"Heliyon"},{"key":"2026052900270684600_bib8","doi-asserted-by":"publisher","first-page":"g4507","DOI":"10.1136\/bmj.g4507","article-title":"Early identification and management of chronic kidney disease in adults: summary of updated NICE guidance","volume":"349","author":"Carville","year":"2014","journal-title":"BMJ"},{"key":"2026052900270684600_bib9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/jdi.14293","article-title":"The health-economic impact of urine albumin-to-creatinine ratio testing for chronic kidney disease in Japanese patients with type 2 diabetes","volume":"16","author":"Asahi","year":"2025","journal-title":"J Diabetes Invest"},{"key":"2026052900270684600_bib10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10157-024-02600-9","article-title":"The health-economic impact of urine albumin-to-creatinine ratio testing for chronic kidney disease in Japanese non-diabetic patients","volume":"29","author":"Konta","year":"2025","journal-title":"Clin Exp Nephrol"},{"key":"2026052900270684600_bib11","first-page":"97","article-title":"Laboratory measurement of urine albumin and urine total protein in screening for proteinuria in chronic kidney disease","volume":"32","author":"Martin","year":"2011","journal-title":"Clin Biochem Rev"},{"key":"2026052900270684600_bib12","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1309\/LMKRNRGW5J03APZQ","article-title":"Proteins and albumin","volume":"45","author":"Bertholf","year":"2014","journal-title":"Lab Med"},{"key":"2026052900270684600_bib13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M23-2814","article-title":"Association of albuminuria with chronic kidney disease progression in persons with chronic kidney disease and normoalbuminuria: a cohort study","volume":"177","author":"Verma","year":"2024","journal-title":"Ann Intern Med"},{"key":"2026052900270684600_bib14","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1056\/NEJMra2201153","article-title":"Uses of GFR and albuminuria level in acute and chronic kidney disease","volume":"386","author":"Levey","year":"2022","journal-title":"N Engl J Med"},{"key":"2026052900270684600_bib15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S2213-8587(18)30314-0","article-title":"Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials","volume":"7","author":"Heerspink","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026052900270684600_bib16","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2215\/CJN.11511114","article-title":"Albuminuria is an appropriate therapeutic target in patients with CKD: the pro view","volume":"10","author":"Lambers Heerspink","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026052900270684600_bib17","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","journal-title":"Kidney Int"},{"key":"2026052900270684600_bib18","first-page":"5","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Eknoyan","year":"2013","journal-title":"Kidney Int"},{"key":"2026052900270684600_bib19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/ki.2013.444","article-title":"Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward","volume":"85","author":"Levin","year":"2014","journal-title":"Kidney Int"},{"key":"2026052900270684600_bib20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.kisu.2017.10.003","article-title":"Diagnosis of diabetic kidney disease: state of the art and future perspective","volume":"8","author":"Persson","year":"2018","journal-title":"Kidney Int Suppl"},{"key":"2026052900270684600_bib21","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.2215\/CJN.0000000839","article-title":"Effects of therapies on proteinuria and eGFR in IgA nephropathy: meta-analysis of randomized trials","volume":"20","author":"Kim","year":"2025","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026052900270684600_bib22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41591-025-04057-z","article-title":"A meta-analysis of albuminuria as a surrogate endpoint for kidney failure","volume":"32","author":"Heerspink","year":"2026","journal-title":"Nat Med"},{"key":"2026052900270684600_bib23","doi-asserted-by":"publisher","first-page":"32","DOI":"10.7326\/ANNALS-25-02117","article-title":"Proteinuria or albuminuria as markers of kidney and cardiovascular disease risk\u202f: an individual patient-level meta-analysis","volume":"179","author":"Heerspink","year":"2026","journal-title":"Ann Intern Med"},{"key":"2026052900270684600_bib24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/ndt\/gfae085","article-title":"Albuminuria predicts kidney events in IgA nephropathy","volume":"40","author":"Faucon","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026052900270684600_bib25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/ndt\/gfaf189","article-title":"Albuminuria and kidney disease progression in IgA nephropathy in China","volume":"41","author":"Yu","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026052900270684600_bib26","doi-asserted-by":"publisher","first-page":"sfae230","DOI":"10.1093\/ckj\/sfae230","article-title":"Long-term outcomes of patients with IgA nephropathy in the German CKD cohort","volume":"17","author":"Stamellou","year":"2024","journal-title":"Clin Kidney J"},{"key":"2026052900270684600_bib27","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2215\/CJN.0000000000000135","article-title":"Long-term outcomes in IgA nephropathy","volume":"18","author":"Pitcher","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026052900270684600_bib28","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1093\/ndt\/gfaf084","article-title":"CKD progression, kidney failure, and mortality among US patients with IgA nephropathy","volume":"40","author":"Sim","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026052900270684600_bib29","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/ndt\/gfae252","article-title":"Long-term outcomes of IgA nephropathy in China","volume":"40","author":"Shen","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026052900270684600_bib30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ndt\/gfae151","article-title":"The use of albuminuria or proteinuria for risk prediction in IgAN","volume":"40","author":"Cheung","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2026052900270684600_bib31","doi-asserted-by":"publisher","first-page":"809245","DOI":"10.3389\/fmed.2022.809245","article-title":"Comparison of 24-h urine protein, urine albumin-to-creatinine ratio, and protein-to-creatinine ratio in IgA nephropathy","volume":"9","author":"Yu","year":"2022","journal-title":"Front Med"},{"key":"2026052900270684600_bib32","doi-asserted-by":"publisher","first-page":"947","DOI":"10.2215\/CJN.10150915","article-title":"Measures of urinary protein and albumin in the prediction of progression of IgA nephropathy","volume":"11","author":"Zhao","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026052900270684600_bib33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.6061\/clinics\/2016(05)01","article-title":"The urine albumin-to-creatinine ratio is a reliable indicator for evaluating complications of chronic kidney disease and progression in IgA nephropathy in China","volume":"71","author":"Huan","year":"2016","journal-title":"Clinics"},{"key":"2026052900270684600_bib34","doi-asserted-by":"publisher","first-page":"sfae379","DOI":"10.1093\/ckj\/sfae379","article-title":"Albuminuria after induction treatment and kidney prognosis in ANCA-associated glomerulonephritis","volume":"18","author":"Chalkia","year":"2025","journal-title":"Clin Kidney J"},{"key":"2026052900270684600_bib35","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the treatment of ANCA-associated vasculitis","volume":"384","author":"Jayne","year":"2021","journal-title":"N Engl J Med"},{"key":"2026052900270684600_bib36","doi-asserted-by":"publisher","first-page":"gfaf176","DOI":"10.1093\/ndt\/gfaf176","article-title":"Albuminuria or proteinuria for response assessment and follow-up in lupus nephritis","author":"Navarro-S\u00e1nchez","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026052900270684600_bib37","doi-asserted-by":"publisher","first-page":"631","DOI":"10.12659\/MSM.899973","article-title":"Urinary albumin levels are independently associated with renal lesion severity in patients with lupus nephritis and little or no proteinuria","volume-title":"Med Sci Monit","author":"Ding","year":"2017"},{"key":"2026052900270684600_bib38","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3899\/jrheum.2024-1087","article-title":"Prevalence, risk factors, and outcomes of chronic kidney disease in patients with systemic lupus erythematosus with and without lupus nephritis","volume":"52","author":"Cohen-Hagai","year":"2025","journal-title":"J Rheumatol"},{"key":"2026052900270684600_bib39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ekir.2024.10.021","article-title":"Long-term outcomes of lupus nephritis in comparison to other CKD etiologies","volume":"10","author":"Chrysostomou","year":"2025","journal-title":"Kidney Int Rep"},{"key":"2026052900270684600_bib40","doi-asserted-by":"publisher","first-page":"e14427","DOI":"10.1111\/nep.14427","article-title":"Lupus nephritis and chronic kidney disease: a scoping review","volume":"30","author":"Teoh","year":"2025","journal-title":"Nephrology"},{"key":"2026052900270684600_bib41","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41584-024-01158-w","article-title":"Lupus nephritis-related chronic kidney disease","volume":"20","author":"Lichtnekert","year":"2024","journal-title":"Nat Rev Rheumatol"},{"issue":"Suppl_2","key":"2026052900270684600_bib42","doi-asserted-by":"publisher","first-page":"ii50","DOI":"10.1093\/ndt\/gfad069","article-title":"CKD therapy to improve outcomes of immune-mediated glomerular diseases","volume":"38","author":"Anders","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2026052900270684600_bib43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ard.2025.09.007","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update","volume":"85","author":"Fanouriakis","year":"2026","journal-title":"Ann Rheum Dis"},{"key":"2026052900270684600_bib44","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/acr.24263","article-title":"Comparison of the 2019 European Alliance of Associations for Rheumatology\/American College of Rheumatology systemic lupus erythematosus classification criteria with two sets of earlier systemic lupus erythematosus classification criteria","volume":"73","author":"Petri","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026052900270684600_bib45","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25690","article-title":"2025 American College of Rheumatology (ACR) guideline for the treatment of systemic lupus erythematosus","author":"Sammaritano","year":"2025","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026052900270684600_bib46","doi-asserted-by":"publisher","first-page":"S713","DOI":"10.1136\/annrheumdis-2020-216924","article-title":"2019 update of the joint European League against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of lupus nephritis","volume":"79","author":"Fanouriakis","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2026052900270684600_bib47","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2025.04.004","article-title":"KDIGO 2025 clinical practice guideline for the management of immunoglobulin a nephropathy (IgAN) and immunoglobulin a vasculitis (IgAV)","volume":"108","author":"Kidney Disease: Improving Global Outcomes (KDIGO) IgAN and IgAV Work Group","year":"2025","journal-title":"Kidney Int"},{"key":"2026052900270684600_bib48","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/art.39594","article-title":"Risk of end-stage renal disease in patients with lupus nephritis, 1971-2015: a systematic review and bayesian meta-analysis","volume":"68","author":"Tektonidou","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2026052900270684600_bib49","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/ndt\/gfw046","article-title":"End-stage renal disease in ANCA-associated vasculitis","volume":"32","author":"Moiseev","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2026052900270684600_bib50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.34067\/KID.0006172020","article-title":"Focal segmental glomerulosclerosis, risk factors for end stage kidney disease, and response to immunosuppression","volume":"2","author":"Forster","year":"2021","journal-title":"Kidney360"},{"key":"2026052900270684600_bib51","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/ndt\/gfaf033","article-title":"Disease-modifying anti-nephropathic drugs (DMANDs)-a definition proposed by the Immunonephrology Working Group (IWG) of the European Renal Association (ERA)","volume":"40","author":"Teng","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026052900270684600_bib52","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1046\/j.1523-1755.2002.00390.x","article-title":"The urinary excretion of IgG and alpha1-microglobulin predicts renal outcome and identifies patients deserving treatment in membranous nephropathy","volume":"61","author":"Bazzi","year":"2002","journal-title":"Kidney Int"},{"key":"2026052900270684600_bib53","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1053\/ajkd.2001.26080","article-title":"Urinary excretion of IgG and alpha(1)-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy","volume":"38","author":"Bazzi","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"2026052900270684600_bib54","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1053\/ajkd.2003.50040","article-title":"Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glomerulosclerosis: a pilot study","volume":"41","author":"Bazzi","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"2026052900270684600_bib55","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1681\/ASN.0000000000000331","article-title":"The challenge of assessing remission and relapse in ANCA kidney disease","volume":"35","author":"Brix","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"2026052900270684600_bib56","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1007\/s11255-025-04440-2","article-title":"The global burden of chronic kidney disease due to glomerulonephritis: trends and predictions","volume":"57","author":"Wang","year":"2025","journal-title":"Int Urol Nephrol"},{"key":"2026052900270684600_bib57","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2215\/CJN.0000000000000017","article-title":"Global, regional, and national burden of CKD due to glomerulonephritis from 1990 to 2019: a systematic analysis from the global burden of disease study 2019","volume":"18","author":"Hu","year":"2023","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfag020\/66957959\/gfag020.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/6\/991\/66957959\/gfag020.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/6\/991\/66957959\/gfag020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:27:15Z","timestamp":1780028835000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/41\/6\/991\/8488589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":57,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,2,17]]},"published-print":{"date-parts":[[2026,5,29]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfag020","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,2,17]]}}}